Seeing Is Believing
CRDL is currently covered by 3 analysts with an average price target of $4.23. This is a potential upside of $2.43 (135%) from yesterday's end of day stock price of $1.8.
Cardiol Therapeutics's activity chart (see below) currently has 2 price targets and 8 ratings on display. The stock rating distribution of CRDL is 75% BUY and 25% HOLD.
Highest price target for CRDL is $3, Lowest price target is $3, average price target is $4.23.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 14-Aug-2023.
Currently out of the existing stock ratings of CRDL, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
3
$1.2 (66.67%)
8
7 months 14 days ago
0/2 (0%)
$2.07 (222.58%)
Buy
7
10 months 9 days ago
0/2 (0%)
$5.22 (293.26%)
What is CRDL (Cardiol Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CRDL (Cardiol Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CRDL (Cardiol Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CRDL (Cardiol Therapeutics)?
Which analyst is the currently most bullish on CRDL (Cardiol Therapeutics)?
Which analyst is the currently most reserved on CRDL (Cardiol Therapeutics)?